Literature DB >> 23664093

Clinical significance of surgery for gastric submucosal tumours with size enlargement during watchful waiting period.

Yasuhiro Miyazaki1, Kiyokazu Nakajima, Yukinori Kurokawa, Tsuyoshi Takahashi, Shuji Takiguchi, Hiroshi Miyata, Makoto Yamasaki, Seiichi Hirota, Toshirou Nishida, Masaki Mori, Yuichiro Doki.   

Abstract

BACKGROUND: The true impact of surgery for small, asymptomatic and biopsy-negative gastric submucosal tumours (SMTs) with size enlargement during 'watchful waiting' period has not been fully understood.
METHODS: From 2005 to 2012, 100 patients with gastric SMTs underwent surgery. Twenty-three of them with size enlargement during observation period were enrolled in the retrospective analysis. Data included clinicopathologic findings, genetic findings, operative outcomes and prognoses.
RESULTS: All patients (13 males, 10 females), with median age of 54 (41-71), had their lesions detected by routine health check-up (n=21) or incidentally (2). The tumours were 1.8 (0.5-4.0)cm in size at their initial detection, and enlarged up to 3.2 (2.0-7.0)cm at the operation during 63.0 (14.6-233.7) months. As surgical procedure, laparoscopic partial gastrectomy accounted for the majority (78.3%). Histologic examination revealed gastrointestinal stromal tumour (GIST) (21) and schwannoma (2). Although 16 out of 21 GISTs were categorised into 'Very low' (1), and 'Low' (13) risk according to Fletcher's classification, 'Intermediate' (5) and 'High' (2) risk were identified in the series. No recurrences/metastases were noted in 23.2 (0.9-87) months of postoperative follow-up.
CONCLUSION: Our study revealed the existence of high mitotic GISTs in asymptomatic, small gastric SMTs with size enlargement, and laparoscopic surgery was safely applied to majority of those cases. Prompt surgical intervention should therefore be considered for those lesions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GIST; Gastrointestinal stromal tumour; Guidelines; Incidental GIST; Laparoscopic surgery; Mitosis; NCCN; Risk stratification; Submucosal tumour

Mesh:

Year:  2013        PMID: 23664093     DOI: 10.1016/j.ejca.2013.04.006

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Gastric sub-epithelial tumors: identification of gastrointestinal stromal tumors using CT with a practical scoring method.

Authors:  Ming Liu; Liheng Liu; Erhu Jin
Journal:  Gastric Cancer       Date:  2018-12-09       Impact factor: 7.370

2.  Management of early asymptomatic gastrointestinal stromal tumors of the stomach.

Authors:  Hans Scherübl; Siegbert Faiss; Wolfram-Trudo Knoefel; Eva Wardelmann
Journal:  World J Gastrointest Endosc       Date:  2014-07-16

3.  The role of endoscopy in the diagnosis of gastric gastrointestinal stromal tumors.

Authors:  Toshirou Nishida
Journal:  Ann Surg Oncol       Date:  2015-03-31       Impact factor: 5.344

4.  Small EUS-suspected gastrointestinal stromal tumors of the stomach: An overview for the current state of management.

Authors:  Ender Gunes Yegin; Deniz Guney Duman
Journal:  Endosc Ultrasound       Date:  2016 Mar-Apr       Impact factor: 5.628

5.  Gastric Schwannoma: A Tumor Must Be Included in Differential Diagnoses of Gastric Submucosal Tumors.

Authors:  Bao-Guang Hu; Feng-Jie Wu; Jun Zhu; Xiao-Mei Li; Yu-Ming Li; Yan Feng; He-Sheng Li
Journal:  Case Rep Gastrointest Med       Date:  2017-05-09

6.  A case of a diverticulum-like giant jejunal gastrointestinal stromal tumour presenting with intraperitoneal peritonitis due to rupture.

Authors:  Ryosuke Arata; Hideki Nakahara; Takashi Urushihara; Toshiyuki Itamoto; Takashi Nishisaka
Journal:  Int J Surg Case Rep       Date:  2020-04-01

7.  Traumatic neuroma of remnant cystic duct mimicking duodenal subepithelial tumor: A case report.

Authors:  Dong-Hwan Kim; Ji-Ho Park; Jin-Kyu Cho; Jung-Wook Yang; Tae-Han Kim; Sang-Ho Jeong; Young-Hye Kim; Young-Joon Lee; Soon-Chan Hong; Eun-Jung Jung; Young-Tae Ju; Chi-Young Jeong; Ju-Yeon Kim
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.